{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:07:48Z","timestamp":1733288868618,"version":"3.30.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74998","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:35:40Z","timestamp":1733200540000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Pleural Mesothelioma: A Challenge in Early Diagnosis"],"prefix":"10.7759","author":[{"given":"Ancuta-Alina","family":"Constantin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin Dumitru","family":"Mihaltan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela-Stefania","family":"Marghescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Andreea","family":"Craciunica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pleural malignancy","author":"Davies H","year":"2021","unstructured":"Davies H, Sterman D, Lee YC. Pleural malignancy. Murray & Nadel's Textbook of Respiratory Medicine, 7th edition. Broaddus VC, Ernst JD, King TE Jr, et al. (ed): Elsevier, Philadelphia, PA; 2021. 2:1575-89."},{"key":"ref2","article-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Malignant Pleural Mesothelioma, Version 1.2022 \u2014 December 22","year":"2022","unstructured":"NCCN Guidelines for Patients. Malignant Pleural Mesothelioma.  National Comprehensive Cancer Network, Inc. , Plymouth Meeting, PA; 2022. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/mpm-patient.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3436-0","article-title":"Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973-2013","volume":"11","author":"Kerger BD","year":"2018","unstructured":"Kerger BD. Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973-2013. BMC Res Notes. 2018, 11:337. 10.1186\/s13104-018-3436-0","journal-title":"BMC Res Notes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30237","article-title":"The epidemiology of mesothelioma","volume":"29","author":"Britton M","year":"2002","unstructured":"Britton M. The epidemiology of mesothelioma. Semin Oncol. 2002, 29:18-25. 10.1053\/sonc.2002.30237","journal-title":"Semin Oncol"},{"key":"ref5","article-title":"Pleureziile serofibrinoase","author":"Macri A","year":"2008","unstructured":"Macri A, Stoicescu IP. Pleureziile serofibrinoase. Pneumologia [Book in Romanian]. Bogdan MA (ed): Editura Universitar\u0103 Bucure\u0219ti, Bucure\u0219ti; 2008. 335-54."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164194","article-title":"Epidemiology and clinical aspects of malignant pleural mesothelioma","volume":"13","author":"Brims F","year":"2021","unstructured":"Brims F. Epidemiology and clinical aspects of malignant pleural mesothelioma. Cancers (Basel). 2021, 13:4194. 10.3390\/cancers13164194","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.10.005","article-title":"Prediction modelling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients undergoing cytoreductive surgery","volume":"14","author":"Harris EJ","year":"2019","unstructured":"Harris EJ, Kao S, McCaughan B, et al.. Prediction modelling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients undergoing cytoreductive surgery. J Thorac Oncol. 2019, 14:288-93. 10.1016\/j.jtho.2018.10.005","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2225-319X.2012.11.04","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson BM","year":"2012","unstructured":"Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012, 1:491-6. 10.3978\/j.issn.2225-319X.2012.11.04","journal-title":"Ann Cardiothorac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20210129","article-title":"Malignant pleural mesothelioma: an update","volume":"47","author":"Hajj GN","year":"2021","unstructured":"Hajj GN, Cavarson CH, Pinto CA, Venturi G, Navarro JR, Lima VC. Malignant pleural mesothelioma: an update. J Bras Pneumol. 2021, 47:e20210129. 10.36416\/1806-3756\/e20210129","journal-title":"J Bras Pneumol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1073-8","article-title":"Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients","volume":"60","author":"Suzuki K","year":"2011","unstructured":"Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS. Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunol Immunother. 2011, 60:1721-8. 10.1007\/s00262-011-1073-8","journal-title":"Cancer Immunol Immunother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores RM","year":"2007","unstructured":"Flores RM, Zakowski M, Venkatraman E, et al.. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol. 2007, 2:957-65. 10.1097\/JTO.0b013e31815608d9","journal-title":"J Thorac Oncol"},{"key":"ref12","article-title":"Malignant pleural mesothelioma","author":"Meniawy T","year":"2012","unstructured":"Meniawy T, Robinson B. Malignant pleural mesothelioma. Clinical Respiratory Medicine, Fourth edition. Spiro SG, Silvestri GA, Agust\u00ed A (ed): Elsevier Saunders, Philadelphia, PA; 2012. 837-45."},{"key":"ref13","unstructured":"Radiopaedia. Mesothelioma. (2024). Accessed: August 29, 2024: https:\/\/radiopaedia.org\/articles\/mesothelioma."},{"key":"ref14","article-title":"Presentation, initial evaluation, and prognosis of malignant pleural mesothelioma","author":"Sterman DH","year":"2024","unstructured":"Sterman DH, Litzky LA, Kaiser LR. Presentation, initial evaluation, and prognosis of malignant pleural mesothelioma. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2313","article-title":"A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters","volume":"16","author":"Nowak AK","year":"2010","unstructured":"Nowak AK, Francis RJ, Phillips MJ, et al.. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res. 2010, 16:2409-17. 10.1158\/1078-0432.CCR-09-2313","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis RJ","year":"2007","unstructured":"Francis RJ, Byrne MJ, van der Schaaf AA, et al.. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med. 2007, 48:1449-58. 10.2967\/jnumed.107.042333","journal-title":"J Nucl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0226-2020","article-title":"Update on biology and management of mesothelioma","volume":"30","author":"Asciak R","year":"2021","unstructured":"Asciak R, George V, Rahman NM. Update on biology and management of mesothelioma. Eur Respir Rev. 2021, 30:159. 10.1183\/16000617.0226-2020","journal-title":"Eur Respir Rev"},{"key":"ref18","article-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","year":"2015","unstructured":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (ed). International Agency for Research on Cancer, Lyon, France; 2015."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-013-0045-1","article-title":"Prognostic factors for malignant pleural mesothelioma","author":"Brims FJ","year":"2013","unstructured":"Brims FJ, Maskell NA. Prognostic factors for malignant pleural mesothelioma. Curr Respir Care Rep. 2013, 100-8. 10.1007\/s13665-013-0045-1","journal-title":"Curr Respir Care Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.050","article-title":"Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials","volume":"23","author":"Fennell DA","year":"2005","unstructured":"Fennell DA, Parmar A, Shamash J, et al.. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol. 2005, 23:184-9. 10.1200\/JCO.2005.07.050","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2006.01.004","article-title":"Management of malignant pleural mesothelioma","volume":"27","author":"West SD","year":"2006","unstructured":"West SD, Lee YC. Management of malignant pleural mesothelioma. Clin Chest Med. 2006, 27:335-54. 10.1016\/j.ccm.2006.01.004","journal-title":"Clin Chest Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0346","article-title":"Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma","volume":"19","author":"Creaney J","year":"2010","unstructured":"Creaney J, Olsen NJ, Brims F, et al.. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Cancer Epidemiol Biomarkers Prev. 2010, 19:2238-46. 10.1158\/1055-9965.EPI-10-0346","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney J","year":"2011","unstructured":"Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ, Nowak AK. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden. Clin Cancer Res. 2011, 17:1181-9. 10.1158\/1078-0432.CCR-10-1929","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205205","article-title":"Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma","volume":"69","author":"Creaney J","year":"2014","unstructured":"Creaney J, Dick IM, Meniawy TM, et al.. Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Thorax. 2014, 69:895-902. 10.1136\/thoraxjnl-2014-205205","journal-title":"Thorax"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby AC","year":"2018","unstructured":"Bibby AC, Dorn P, Psallidas I, et al.. ERS\/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018, 52:10.1183\/13993003.00349-2018","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317806-diffuse-pleural-mesothelioma-a-challenge-in-early-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:36:08Z","timestamp":1733200568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317806-diffuse-pleural-mesothelioma-a-challenge-in-early-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.74998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}